Table 5. PEDro scale of quality for eligible randomized controlled trials.
| First Author, year | Eligibility criteria* | Random allocation | Concealed allocation | Similar at baseline | Blind subjects | Blind therapist | Blind assessors | < 15% dropout | Intention-to-treat analysis | Between-group comparison | Point measures and variability data | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Picelli, 2016 [39] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | 1 | 1 | 1 | 9 |
| Rios Romenets, 2015 [34] | 1 | 1 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 9 |
| Duchesne, 2015 [32] | 1 | - | - | 1 | - | - | - | - | — | 1 | 1 | 3 |
| Nadeau, 2014 [33] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | 1 | 1 | 8 |
| Nocera, 2013 [36] | 1 | 1 | - | 1 | - | - | 1 | 1 | - | 1 | 1 | 6 |
| McKee, 2013 [35] | 1 | - | - | 1 | - | - | 1 | - | - | 1 | 1 | 4 |
| Pompeu, 2012 [37] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | 1 | 1 | 8 |
| Cruise, 2011 [40] | 1 | - | - | 1 | - | - | - | 1 | - | 1 | 1 | 4 |
| Tanaka, 2009 [38] | 1 | - | - | 1 | - | - | - | - | - | 1 | 1 | 3 |
Note:
* Criterion 1 is not considered for the final score because it is an item that assesses the external validity. [41]
Source: Author’s own production